TR199700109A2 - Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac. - Google Patents

Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac.

Info

Publication number
TR199700109A2
TR199700109A2 TR97/00109A TR9700109A TR199700109A2 TR 199700109 A2 TR199700109 A2 TR 199700109A2 TR 97/00109 A TR97/00109 A TR 97/00109A TR 9700109 A TR9700109 A TR 9700109A TR 199700109 A2 TR199700109 A2 TR 199700109A2
Authority
TR
Turkey
Prior art keywords
diagnostics
medicines
manufacture
carbonic acid
medicament containing
Prior art date
Application number
TR97/00109A
Other languages
English (en)
Inventor
Dr Jan-Robert Schwark
Dr Joachim Brendel
Dr Heinz-Werner Kleemann
Dr Hans Jochen Lang
Dr Andreas Weichert
Dr Udo Albus
Dr Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of TR199700109A2 publication Critical patent/TR199700109A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR97/00109A 1996-02-15 1997-02-13 Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac. TR199700109A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19605610A DE19605610A1 (de) 1996-02-15 1996-02-15 Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
TR199700109A2 true TR199700109A2 (tr) 1997-09-21

Family

ID=7785491

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00109A TR199700109A2 (tr) 1996-02-15 1997-02-13 Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac.

Country Status (29)

Country Link
US (1) US5756535A (tr)
EP (1) EP0790245B1 (tr)
JP (1) JP4402747B2 (tr)
KR (1) KR970061887A (tr)
AR (1) AR005812A1 (tr)
AT (1) ATE202096T1 (tr)
AU (1) AU706554B2 (tr)
BR (1) BR9700990A (tr)
CA (1) CA2197628C (tr)
CZ (1) CZ45597A3 (tr)
DE (2) DE19605610A1 (tr)
DK (1) DK0790245T3 (tr)
ES (1) ES2158383T3 (tr)
GR (1) GR3036122T3 (tr)
HR (1) HRP970081B1 (tr)
HU (1) HUP9700437A3 (tr)
ID (1) ID15889A (tr)
IL (1) IL120214A (tr)
MX (1) MX9701163A (tr)
NO (1) NO315424B1 (tr)
NZ (1) NZ314230A (tr)
PL (1) PL318412A1 (tr)
PT (1) PT790245E (tr)
RU (1) RU2193033C2 (tr)
SI (1) SI0790245T1 (tr)
SK (1) SK282440B6 (tr)
TR (1) TR199700109A2 (tr)
TW (1) TW445261B (tr)
ZA (1) ZA971260B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634229A1 (de) * 1996-08-23 1998-02-26 Basf Ag Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
CA2370607A1 (en) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
BRPI0213393B8 (pt) 2001-10-19 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
RU2193033C2 (ru) 2002-11-20
AU706554B2 (en) 1999-06-17
DE59703746D1 (de) 2001-07-19
PL318412A1 (en) 1997-08-18
NO970697L (no) 1997-08-18
JP4402747B2 (ja) 2010-01-20
ZA971260B (en) 1997-08-15
HUP9700437A2 (hu) 1998-08-28
SI0790245T1 (en) 2001-08-31
EP0790245A1 (de) 1997-08-20
ES2158383T3 (es) 2001-09-01
AU1265997A (en) 1997-08-21
AR005812A1 (es) 1999-07-14
ATE202096T1 (de) 2001-06-15
NO315424B1 (no) 2003-09-01
US5756535A (en) 1998-05-26
HU9700437D0 (en) 1997-04-28
MX9701163A (es) 1997-08-30
KR970061887A (ko) 1997-09-12
CA2197628A1 (en) 1997-08-16
SK282440B6 (sk) 2002-02-05
SK21397A3 (en) 1997-09-10
HRP970081A2 (en) 1998-04-30
HRP970081B1 (en) 2003-04-30
PT790245E (pt) 2001-10-30
CZ45597A3 (en) 1997-09-17
CA2197628C (en) 2006-05-16
IL120214A0 (en) 1997-06-10
GR3036122T3 (en) 2001-09-28
ID15889A (id) 1997-08-14
JPH09249660A (ja) 1997-09-22
HUP9700437A3 (en) 2000-03-28
TW445261B (en) 2001-07-11
DE19605610A1 (de) 1997-08-21
EP0790245B1 (de) 2001-06-13
NO970697D0 (no) 1997-02-14
IL120214A (en) 2000-08-31
DK0790245T3 (da) 2001-09-03
BR9700990A (pt) 1998-09-01
NZ314230A (en) 1997-12-19

Similar Documents

Publication Publication Date Title
ITRM930301A0 (it) Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
ITGE930016A0 (it) Sistema elettrochirurgico trequarti,cosidetto "trocar".
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
TR199600873A2 (tr) Ikame edilmis sülfonimidamid'ler, bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve ayrica bunlari ihtiva eden ilaclar.
DE3674582D1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
DE58905246D1 (de) Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
TR28873A (tr) N-sübstitüe edilmis, N,N'-kaynasik heterosiklik benzoik asit üretmeye mahsus yöntem.
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
TR199600118A2 (tr) Sübstitüe edilmis benzolsulfonil üreler ve tioüreler, bunlarin üretilmesine mahsus usul, ilac veya diyagnostik olarak kullanilmalari ve bunlari ihtiva eden ilac.
TR199700109A2 (tr) Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac.
ITRM930502A0 (it) Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
TR26907A (tr) Yeni poliiodine bilesikleri, hazirlik prosesi ve bunlari iceren kontrast maddesi.
ZA976735B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them.
KR960701075A (ko) 신규 2'-메틸리덴 뉴클레오티드 화합물, 그의 제조 방법 및 그의 약학적 용도[novel 2'-methylidenenucleotide compound, process for producing the same, and pharmaceutical use thereof]
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
ID21968A (id) Turunan-turunan 11-asetil-12, 13-dioksabisiklo (8.2.1)-tridesenon, proses pembuatannya dan senyawa yang digunakan sebagai obat
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO985550D0 (no) FremgangsmÕte for fremstilling av 2,2'-(1-metyl-1,2-etandiyliden)bis(hydrazinkarboksimidamid)